Oxidative protein damage negatively affects protein-protein interaction: The case of KRAS-cRAF
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Marina Rudan Dimlić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mediterranean Institute for Life Sciences, Split, Croatia. Electronic address: marina.rudandimlic@medils.hr. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Oxidative Stress, Proto-Oncogene Proteins c-raf, Ultraviolet Rays. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Protein-protein interactions (PPIs) play crucial roles in cellular signaling, transmitting signals from the cell surface to its interior. One of the most important signaling cascades is the RAS-RAF-MEK-ERK pathway. This pathway is initiated by various upstream signaling reactions, including receptor tyrosine kinase (RTK) activation, and it controls many biological functions like cell proliferation, differentiation, and survival. Once RAS is activated, it binds RAF and relays the signal to downstream proteins. The RAS-binding domain (RBD) in RAF protein plays a crucial role in this process, facilitating the RAS-ERK pathway signaling. In this study, we explored the effect of oxidative stress induced by UV radiation on the KRAS-RBD interaction. Using the Split Intein-Mediated Protein Ligation (SIMPL) method, we assessed the impact of different UV doses on KRAS-RBD interactions and observed a disruption of this interaction at higher doses. UV-treated samples exhibited high levels of protein carbonylation, as detected by Oxime Blot and mass spectrometry (MS) analysis, indicating oxidative damage. The MS results provided detailed insights into specific carbonylation modifications on the KRAS protein. Our study demonstrates that protein oxidation and carbonylation can disrupt protein-protein interactions, specifically the KRAS/c-RAF interaction. These findings highlight the impact of oxidative stress on signaling pathways, such as those triggered by UV irradiation. A deeper understanding of these molecular changes may aid in developing therapies targeting diseases linked to oxidative stress, including cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mediterranean Institute for Life Sciences, Split, Croatia. Electronic address: marina.rudandimlic@medils.hr.
- Mediterranean Institute for Life Sciences, Split, Croatia.
- Department of Chemistry, Faculty of Science, University of Zagreb, Zagreb, Croatia.
- Department of Physics, Faculty of Science, University of Split, Split, Croatia.
- Donnelly Centre, University of Toronto, Temerty School of Medicine, Ontario, Canada.
- Mediterranean Institute for Life Sciences, Split, Croatia; Donnelly Centre, University of Toronto, Temerty School of Medicine, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Ontario, Canada; D…
Zitieren
APA
Rudan Dimlić, M., Raić, S., Močibob, M., Sanader Maršić, Ž., Yao, Z., Radman, M., & Stagljar, I. (2024). Oxidative protein damage negatively affects protein-protein interaction: The case of KRAS-cRAF. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150792
Vancouver
Rudan Dimlić M, Raić S, Močibob M, Sanader Maršić Ž, Yao Z, Radman M, et al. Oxidative protein damage negatively affects protein-protein interaction: The case of KRAS-cRAF. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150792
BibTeX
@article{RudanDimli2024,
author = {Rudan Dimlić, Marina and Raić, Sanda and Močibob, Marko and Sanader Maršić, Željka and Yao, Zhong and Radman, Miroslav and Stagljar, Igor},
title = {Oxidative protein damage negatively affects protein-protein interaction: The case of KRAS-cRAF},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150792}
}
EUVIMED